High-dose therapy with autologous PBSC transplantation in the front-line treatment of Waldenstrom's macroglobulinemia

Bone Marrow Transplant. 2009 Apr;43(7):587-8. doi: 10.1038/bmt.2008.360. Epub 2008 Nov 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology
  • Humans
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation*
  • Rituximab
  • Waldenstrom Macroglobulinemia / therapy*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Rituximab